Does omalizumab use in chronic spontaneous urticaria results in improvement in sexual functions?

Basit Öğe Kaydı
dc.contributor.authorDurmaz, Koray
dc.contributor.authorAtaseven, Arzu
dc.contributor.authorTemiz, Selami Aykut
dc.contributor.authorIsik, Begum
dc.contributor.authorDursun, Recep
dc.date.accessioned2024-02-23T14:24:30Z
dc.date.available2024-02-23T14:24:30Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractBackground Chronic spontaneous urticaria (CSU) is a disease that can affect the patient's quality of life (QoL), sexual functions, and mood. Objective We planned a retrospective study to investigate the effects of omalizumab use in CSU patients on sexual function. We also aimed to evaluate the sexual function, quality of life (QoL), and mood of CSU patients compared to the control group consisting of idiopathic pruritus patients. Methods A review of patients' records with CSU attending the dermatology outpatient clinic from January 2020 to June 2020 was done. Urticaria activation score (UAS7), Beck depression inventory (BDI), Dermatology life quality index (DLQI), female sexual function index (FSFI) to female participants, and the international index of erectile function (IIEF) to male participants were used to assess the impact of the disease on patients' life. The obtained data were analyzed by using SPSS software. Results Each one of the mean UAS, BDI, and DLQI score values decreased significantly in weeks in omalizumab group patients. IIEF score in male patients and FSFI score in female patients also increased in weeks in omalizumab group patients. Conclusions Omalizumab can play an effective role in enhancing the sexual function of CSU patients in addition to improving their DLQI.en_US
dc.identifier.doi10.1111/jocd.14872
dc.identifier.endpage4881en_US
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue10en_US
dc.identifier.pmid35184358en_US
dc.identifier.scopus2-s2.0-85125370803en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage4877en_US
dc.identifier.urihttps://doi.org/10.1111/jocd.14872
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13969
dc.identifier.volume21en_US
dc.identifier.wosWOS:000762085900001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal Of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Urticariaen_US
dc.subjectOmalizumaben_US
dc.subjectPsychologicalen_US
dc.subjectQuality Of Lifeen_US
dc.subjectSexual Dysfunctionen_US
dc.titleDoes omalizumab use in chronic spontaneous urticaria results in improvement in sexual functions?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu